BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20019019)

  • 1. Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy.
    Banerjee C; Woller SC; Holm JR; Stevens SM; Lahey MJ
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):345-50. PubMed ID: 20019019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calciphylaxis in dialysis patients, a severe disease poorly responding to therapies: report of 4 cases.
    Savoia F; Gaddoni G; Patrizi A; Misciali C; Odorici G; Tampieri G; Tampieri E; Cantelli S; Aldi M
    G Ital Dermatol Venereol; 2013 Oct; 148(5):531-6. PubMed ID: 24005147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin-Associated Nonuremic Calciphylaxis.
    Yu WY; Bhutani T; Kornik R; Pincus LB; Mauro T; Rosenblum MD; Fox LP
    JAMA Dermatol; 2017 Mar; 153(3):309-314. PubMed ID: 28099971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted approach to a rare clinical case of calciphylaxis in a renal transplant recipient.
    Massimetti C; Bellasi A; Modoni A; Gomes V; Feriozzi S
    G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calciphylaxis in a cardiac patient without renal disease.
    Almafragi A; Vandorpe J; Dujardin K
    Acta Cardiol; 2009 Feb; 64(1):91-3. PubMed ID: 19317304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin-induced calciphylaxis successfully treated with sodium thiosulphate.
    Hafiji J; Deegan P; Brais R; Norris P
    Australas J Dermatol; 2013 May; 54(2):133-5. PubMed ID: 23581997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Painful ulcers in calciphylaxis - combined treatment with maggot therapy and oral pentoxyfillin.
    Tittelbach J; Graefe T; Wollina U
    J Dermatolog Treat; 2001 Dec; 12(4):211-4. PubMed ID: 12241630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K.
    Riegert-Johnson DL; Kaur JS; Pfeifer EA
    Mayo Clin Proc; 2001 Jul; 76(7):749-52. PubMed ID: 11444409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-uremic Calciphylaxis: A Rare and Late Adverse Reaction of Warfarin.
    Patel DM; Patel MV; Patel AD; Kaklotar JC; Patel GR; Patel MM
    Curr Drug Saf; 2019; 14(3):246-248. PubMed ID: 30834840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
    Hayashi M; Takamatsu I; Kanno Y; Yoshida T; Abe T; Sato Y;
    Nephrol Dial Transplant; 2012 Apr; 27(4):1580-4. PubMed ID: 22121234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical calciphylaxis secondary to treatment with acenocoumarol.
    Alvarez-Pérez A; Gutiérrez-González E; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2012 Jan; 103(1):79-81. PubMed ID: 22444506
    [No Abstract]   [Full Text] [Related]  

  • 12. Calciphylaxis in a diabetic patient provoked by warfarin therapy.
    Asobie N; Wong E; Cook MG
    Clin Exp Dermatol; 2008 May; 33(3):342-4. PubMed ID: 18419610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calciphylaxis in dialysis patients: To recognize and treat it as soon as possible].
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Ther; 2010 Nov; 6(6):499-504. PubMed ID: 20627839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1-34)] therapy in the setting of chronic warfarin and glucocorticoid treatment.
    Spanakis EK; Sellmeyer DE
    Osteoporos Int; 2014 Apr; 25(4):1411-4. PubMed ID: 24292108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report of Calciphylaxis Secondary to Calcium and Vitamin D
    Storan ER; O'Gorman SM; Murphy A; Laing M
    J Cutan Med Surg; 2017; 21(2):162-163. PubMed ID: 27566435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calciphylaxis: a favorable outcome with hyperbaric oxygen.
    Dean SM; Werman H
    Vasc Med; 1998; 3(2):115-20. PubMed ID: 9796074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin-induced pulmonary metastatic calcification and calciphylaxis in a patient with end-stage renal disease.
    Cadavid JC; DiVietro ML; Torres EA; Fumo P; Eiger G
    Chest; 2011 Jun; 139(6):1503-1506. PubMed ID: 21652561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?
    Meissner M; Gille J; Kaufmann R
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1037-44. PubMed ID: 17176411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic calciphylaxis.
    Banky JP; Dowling JP; Miles C
    Australas J Dermatol; 2002 Aug; 43(3):190-3. PubMed ID: 12121396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study.
    Dobry AS; Ko LN; St John J; Sloan JM; Nigwekar S; Kroshinsky D
    JAMA Dermatol; 2018 Feb; 154(2):182-187. PubMed ID: 29238798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.